-
-
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic
-
-
Guidelines of the International Headache Society for controlled clinical trials in cluster headache
-
-
Migraine
-
-
Migraine
-
-
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study
-
-
Long-term efficacy and safety of erenumab results from 64 weeks of the LIBERTY study
-
-
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine
-
-
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful
-
-
Migraine: disease characterisation, biomarkers, and precision medicine
-
-
Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
-
-
Response to 'Do different treatment strategies of galcanezumab have similar effect on migraine?'
-
-
Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials
-
-
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
-
-
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis
-
-
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
-
-
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
-
-
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
-
-
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study
-
-
European headache federation consensus on technical investigation for primary headache disorders
-
-
Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study
-
-
Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: Rationale and protocol of a randomised trial
-
-
The International Classification of Headache Disorders, 3rd edition (beta version)
-
-
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse